Hence, targeting the DNA methylation function of UHRF1 via UM164 is a potential therapeutic strategy, which could improve the prognostic outlook of RR B-ALL. The gene discussed is UHRF1; the disease is precursor B-cell acute lymphoblastic leukemia.